Long-Term Cardiovascular Risk for Endometrial Cancer Survivors
TUESDAY, May 8, 2018 -- Endometrial cancer survivors have an elevated risk of various adverse long-term cardiovascular outcomes, according to a study published online May 8 in the Journal of the National Cancer Institute.
Sean Soisson, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news
Endometrial cancer telephone follow-up, a good call
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news
Can Diabetes Lead to Irregular Periods in Teens?
In the long-term, irregular periods can also increase the risk of endometrial cancer, the researchers pointed out in the new report. (Source: WebMD Health)
Source: WebMD Health - April 25, 2018 Category: Consumer Health News Source Type: news
Hologic wins FDA PMA for ThinPrep automated Pap test imager
Hologic (NSDQ:HOLX) said today it won FDA premarket approval for its ThinPrep integrated imager designed for the automated imaging of Pap tests.
The Marlborough, Mass.-based company’s ThinPrep imager is designed to aid cytology technicians in identifying abnormal cells, and combines an imaging station and review scope into a single unit. The system takes approximately 90 seconds to analyze samples, the company said.
“Approval of the ThinPrep Integrated Imager brings the benefits of ThinPrep automated Pap imaging to small- and mid-sized laboratories in the United States, and of course to their patients. Develo...
Source: Mass Device - April 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Imaging Pre-Market Approval (PMA) Women's Health Hologic Source Type: news
Duo win prestigious pathology award for endometrial cancer study
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - April 12, 2018 Category: Cancer & Oncology Source Type: news
Studies Seek Role for Anti-PD-1 Drugs in Gyn Cancers
(MedPage Today) -- Activity in resistant ovarian, mutated endometrial cancers (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 28, 2018 Category: Hematology Source Type: news
Could ER/GR Interplay Affect Endometrial Cancer Prognosis?
Researchers discovered that estrogen receptor alpha and glucocorticoid receptor are simultaneously expressed in many endometrial cancers, and may be associated with poor prognosis. (Source: CancerNetwork)
Source: CancerNetwork - March 28, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Endometrial Cancer News Source Type: news
Everolimus Plus Letrozole Effective in Endometrial Carcinoma
Findings from the GOG-3007 study suggest everolimus plus letrozole might be effective in advanced persistent or recurrent endometrial carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Endometrial Cancer News Conferences/SGO Source Type: news
The connection between diet, obesity, and cancer: Nutrition experts explore the evidence
(Elsevier) About one third of cancer cases are estimated to be linked to dietary and other modifiable risk factors, especially for obesity-related cancers such as breast, colorectal, ovarian, endometrial, kidney, gallbladder, esophageal, and pancreatic cancers. In this special theme issue of the Journal of the Academy of Nutrition and Dietetics, food and nutrition practitioners and other health professionals take an in-depth look at the relationship between nutrition, obesity, and cancer prevention, treatment, and survival and identify research gaps for future prevention research efforts. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2018 Category: International Medicine & Public Health Source Type: news
Updating smear tests could save thousands of women's lives
Researchers from Johns Hopkins University found assessing cervical fluid collected in smears for DNA mutations accurately detects 81 per cent of endometrial and 33 per cent of ovarian cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - March 22, 2018 Category: Consumer Health News Source Type: news
Modified Pap tests can show early warning signs of other gynecological cancers
The Pap test has already reduced the incidence of cervical cancerby more than 60%. Now it may become a key step in the early detection of two other gynecological malignancies — ovarian and endometrial cancers — that have been notorious killers because they’re typically caught so late.A new study... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - March 22, 2018 Category: Science Authors: Melissa Healy Source Type: news
Pap test fluids used in gene-based screening test for two gyn cancers
(Johns Hopkins Medicine) Cervical fluid samples gathered during routine Papanicolaou (Pap) tests are the basis of a new screening test for endometrial and ovarian cancers developed by researchers at the Johns Hopkins Kimmel Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news
Could a Pap Test Spot More Than Cervical Cancer?
The researchers behind the new study developed a testing regimen called PapSEEK to see if additional samples collected during a pelvic exam could be used to detect endometrial or ovarian cancer. (Source: WebMD Health)
Source: WebMD Health - March 21, 2018 Category: Consumer Health News Source Type: news
PapSEEK: Potential Screening Test for Gynecologic Cancers PapSEEK: Potential Screening Test for Gynecologic Cancers
A multiplex panel that detects mutations in endometrial and ovarian cancers using samples from a routine Pap test and that also provides an analysis of aneuploidy may emerge as a screening tool.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Surprising discovery provides insights into aggressive endometrial cancers
(Huntsman Cancer Institute) New research from Huntsman Cancer Institute (HCI) at the University of Utah (U of U) indicates steroid and hormone receptors are simultaneously active in many endometrial cancer tissues. The findings, published today in the journal Cell Reports, yield insights about factors that contribute to more aggressive endometrial tumors (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 13, 2018 Category: Cancer & Oncology Source Type: news
